Overall, these results suggest that the inhibition of central and peripheral PTP1B using genetic circuits may overcome leptin and insulin resistance and provide an attractive strategy to combat obesity. Here, PTPN1 is linked to obesity due to melanocortin 4 receptor deficiency.